The 25 analysts offering 12-month price forecasts for Biogen Inc have a median target of 427.00, with a high estimate of 647.00 and a low estimate of 296.00. The median estimate represents a +46.40% increase from the last price of 291.67.
The current consensus among 31 polled investment analysts is to Hold stock in Biogen Inc. This rating has held steady since September, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.15
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.